Fidelity Investments’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73.7M | Sell |
11,342,699
-2,357,749
| -17% | -$15.3M | ﹤0.01% | 1241 |
|
|
2025
Q1 | $109M | Buy |
13,700,448
+812,981
| +6% | +$6.45M | 0.01% | 1060 |
|
|
2024
Q4 | $163M | Buy |
12,887,467
+5,475,087
| +74% | +$69.4M | 0.01% | 901 |
|
|
2024
Q3 | $103M | Buy |
7,412,380
+4,750,936
| +179% | +$66.2M | 0.01% | 1085 |
|
|
2024
Q2 | $36.7M | Sell |
2,661,444
-1,742,897
| -40% | -$24M | ﹤0.01% | 1433 |
|
|
2024
Q1 | $72.8M | Buy |
4,404,341
+436,175
| +11% | +$7.21M | ﹤0.01% | 1182 |
|
|
2023
Q4 | $57.9M | Sell |
3,968,166
-2,057,962
| -34% | -$30M | ﹤0.01% | 1232 |
|
|
2023
Q3 | $73.9M | Sell |
6,026,128
-1,533,775
| -20% | -$18.8M | 0.01% | 1097 |
|
|
2023
Q2 | $90.3M | Sell |
7,559,903
-1,012,280
| -12% | -$12.1M | 0.01% | 1040 |
|
|
2023
Q1 | $115M | Sell |
8,572,183
-430,128
| -5% | -$5.75M | 0.01% | 936 |
|
|
2022
Q4 | $194M | Buy |
9,002,311
+210,820
| +2% | +$4.54M | 0.02% | 698 |
|
|
2022
Q3 | $176M | Buy |
8,791,491
+1,964,917
| +29% | +$39.4M | 0.02% | 723 |
|
|
2022
Q2 | $122M | Buy |
6,826,574
+4,232,055
| +163% | +$75.8M | 0.01% | 890 |
|
|
2022
Q1 | $25.7M | Sell |
2,594,519
-235,834
| -8% | -$2.34M | ﹤0.01% | 1673 |
|
|
2021
Q4 | $47.7M | Buy |
2,830,353
+668,444
| +31% | +$11.3M | ﹤0.01% | 1438 |
|
|
2021
Q3 | $51.3M | Sell |
2,161,909
-150,541
| -7% | -$3.57M | ﹤0.01% | 1399 |
|
|
2021
Q2 | $52.7M | Buy |
+2,312,450
| New | +$52.7M | ﹤0.01% | 1400 |
|